Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.
Elizabeth S AbyGhady MoafaNyan LattMohammad T SultanPaula A CacioppoSonal KumarRaymond T ChungPatricia Pringle BloomJenna GustafsonMichael DaidoneZoe ReinusJose D DebesSunny SandhuAalam SohalSameeha KhalidMarina RoytmanAndreea Maria CatanaKara WegermannRotonya M CarrYedidya SaimanIhab KassabVincent L ChenAtoosa RabieeCarly RosenbergVeronica NguyenChristina S GaineyKali ZhouKenneth ChavinBlanca C Lizaola-MayoDavid Maxwell Hunter ChascsaLee J VarelasAkshata MogheRenumathy DhanasekaranPublished in: Hepatology communications (2023)
Our large, longitudinal, multicenter study demonstrates a high burden of long-term mortality and morbidity in patients with CLD and COVID-19. Symptoms consistent with long-COVID-19 were present in 30% of patients with CLD. These results illustrate the prolonged implications of COVID-19 both for recovering patients and for health care systems.
Keyphrases
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- respiratory syndrome coronavirus
- peritoneal dialysis
- cross sectional
- cardiovascular events
- prognostic factors
- risk factors
- cardiovascular disease
- patient reported outcomes
- coronary artery disease
- clinical trial
- health insurance